-
1
المؤلفون: Tineke J. Smilde, M.W. Dercksen, Bram Ramaekers, Manon J. Pepels, Birgit E.P.J. Vriens, Vivianne C. G. Tjan-Heijnen, Manuela A. Joore, Xavier Pouwels, Frans L. G. Erdkamp, J.M.G.H. van Riel, N.A.J.B. Peters, Sandra M. E. Geurts, Maaike de Boer, Jose Heijnen-Mommers, Kirsten N. A. Aaldering, Agnes J. van de Wouw
المساهمون: MUMC+: KIO Kemta (9), RS: CAPHRI - R2 - Creating Value-Based Health Care, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde
المصدر: Acta Oncologica, 59(9), 1123-1130. Routledge/Taylor & Francis Group
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cost effectiveness, Cost-Benefit Analysis, Expected value of perfect information, Breast Neoplasms, Drug Costs, 030218 nuclear medicine & medical imaging, COST-EFFECTIVENESS, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Radiology, Nuclear Medicine and imaging, Computer Simulation, Progression-free survival, Registries, Furans, Netherlands, Cost–benefit analysis, business.industry, Hematology, General Medicine, Ketones, Middle Aged, Progression-Free Survival, Cancer registry, Quality-adjusted life year, Models, Economic, chemistry, 030220 oncology & carcinogenesis, Economic evaluation, Insurance, Health, Reimbursement, Disease Progression, Female, Quality-Adjusted Life Years, PRICE, business, Eribulin
-
2
المؤلفون: J.M.G.H. van Riel, M. de Boer, N.A.J.B. Peters, F.P.J. Peters, Vivianne C. G. Tjan-Heijnen, M.W. Dercksen, Tineke J. Smilde, F.W.P.J. van den Berkmortel, Dorien J.A. Lobbezoo, Bram Ramaekers, Manuela A. Joore, R.J.W. van Kampen, A.J. van de Wouw
المساهمون: RS: CAPHRI - R2 - Creating Value-Based Health Care, MUMC+: KIO Kemta (9), MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), MUMC+: TPZ Ergotherapie (9), Health Services Research
المصدر: European Journal of Cancer, 79, 238-246. ELSEVIER SCI LTD
مصطلحات موضوعية: Bridged-Ring Compounds, Oncology, Cancer Research, medicine.medical_specialty, Bevacizumab, Receptor, ErbB-2, Trial based, Breast Neoplasms, Docetaxel, Kaplan-Meier Estimate, PACLITAXEL, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, PLUS DOCETAXEL, Humans, 030212 general & internal medicine, Netherlands, Taxane, Cost–benefit analysis, business.industry, Cost-effectiveness analysis, HER2 negative, Cost-benefit analysis, WOMEN, RANDOMIZED PHASE-III, medicine.disease, Metastatic breast cancer, Surgery, 1ST-LINE TREATMENT, Real-world, 030220 oncology & carcinogenesis, Disease Progression, Health Resources, Female, Taxoids, Quality-Adjusted Life Years, business, medicine.drug, Cohort study
-
3
المؤلفون: Sandra M. E. Geurts, A.J. van de Wouw, Xavier Pouwels, J. Heijnen-Mommers, VC Tjan-Heijnen, N.A.J.B. Peters, Manuela A. Joore, Bram Ramaekers, J.M.G.H. van Riel, Kirsten N. A. Aaldering, Manon J. Pepels, Frans L. G. Erdkamp, Tineke J. Smilde, M. de Boer, Birgit E.P.J. Vriens, M.W. Dercksen
المصدر: Acta Oncologica. 60(5):645-645
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Advanced breast, Hematology, General Medicine, Cancer treatment, Cancer registry, chemistry.chemical_compound, chemistry, Internal medicine, Economic evaluation, Medicine, Radiology, Nuclear Medicine and imaging, business, Eribulin
-
4
المؤلفون: F.P.J. Peters, R.J.W. van Kampen, F.W.P.J. van den Berkmortel, J.M.G.H. van Riel, Dja Lobbezoo, Adri C. Voogd, Pgm Peer, M.W. Dercksen, N.A.J.B. Peters, V.C.G. Tjan-Heijnen, A.J. van de Wouw, Tineke J. Smilde, Manuela A. Joore, M. de Boer
المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Epidemiologie, RS: CAPHRI - R5 - Optimising Patient Care, RS: CAPHRI - R2 - Creating Value-Based Health Care, Health Services Research, MUMC+: KIO Kemta (9)
المصدر: Cancer Treatment and Research Communications, 13, 3-8. Elsevier
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, genetic structures, Bevacizumab, medicine.medical_treatment, Population, Effectiveness, Taxanes, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Internal medicine, medicine, 030212 general & internal medicine, education, Contraindication, Chemotherapy, education.field_of_study, Taxane, business.industry, Real world, Guideline, Metastatic breast cancer, medicine.disease, eye diseases, Implementation, 030220 oncology & carcinogenesis, business, medicine.drug
-
5
المؤلفون: Birgit E.P.J. Vriens, J. Heijnen-Mommers, Frans L. G. Erdkamp, M. de Boer, Bram Ramaekers, VC Tjan-Heijnen, Kirsten N. A. Aaldering, N.A.J.B. Peters, A.J. van de Wouw, Manuela A. Joore, J.M.G.H. van Riel, Manon J. Pepels, Tineke J. Smilde, Xavier Pouwels, S. M. E. Geurts, M.W. Dercksen
المساهمون: MUMC+: KIO Kemta (9), Health Services Research, RS: CAPHRI - R2 - Creating Value-Based Health Care, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Medische Oncologie (9), Interne Geneeskunde
المصدر: Acta Oncologica, 59(1), 82-89. Routledge/Taylor & Francis Group
مصطلحات موضوعية: Oncology, Adult, medicine.medical_specialty, Advanced breast, MONOTHERAPY, MULTICENTER, MESYLATE, CAPECITABINE, TOXICITY, 030218 nuclear medicine & medical imaging, relative effectiveness, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Overall survival, breast neoplasms, Humans, Radiology, Nuclear Medicine and imaging, Registries, Eribulin, Furans, Aged, Netherlands, business.industry, genetic matching, matching, Cancer, Hematology, General Medicine, Ketones, Middle Aged, medicine.disease, EFFICACY, Cancer registry, Cancer treatment, Survival Rate, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, SAFETY, Multivariate Analysis, Female, EXPANDED ACCESS PROGRAM, business
-
6
المؤلفون: M.W. Dercksen, Dorien J.A. Lobbezoo, Gerard Vreugdenhil, Vivianne C. G. Tjan-Heijnen, Petronella G. M. Peer, Adri C. Voogd, N.A.J.B. Peters, Roel J.W. van Kampen, Franchette W P J van den Berkmortel, Rudi M. H. Roumen, Agnes J. van de Wouw, Johanna M. G. H. van Riel, W. Truin, Tineke J. Smilde
المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), Promovendi ODB, Interne Geneeskunde, Epidemiologie, RS: CAPHRI - R5 - Optimising Patient Care, MUMC+: MA Medische Oncologie (9)
المصدر: Oncotarget, 7(20), 29412-29419. Impact Journals LLC
Oncotargetمصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, medicine.medical_specialty, Receptor, ErbB-2, medicine.medical_treatment, Lobular carcinoma, Antineoplastic Agents, Breast Neoplasms, Kaplan-Meier Estimate, Disease-Free Survival, histology, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Internal medicine, invasive lobular carcinoma, medicine, invasive ductal carcinoma, Humans, skin and connective tissue diseases, Survival analysis, Aged, Gynecology, Aged, 80 and over, Chemotherapy, treatment, business.industry, Carcinoma, Ductal, Breast, Bone metastasis, Middle Aged, medicine.disease, Metastatic breast cancer, body regions, Carcinoma, Lobular, 030104 developmental biology, Treatment Outcome, Receptors, Estrogen, Hormone receptor, 030220 oncology & carcinogenesis, Invasive lobular carcinoma, Female, metastatic breast cancer, business, Receptors, Progesterone, Research Paper, Follow-Up Studies
-
7
المؤلفون: F.W.P.J. van den Berkmortel, Tineke J. Smilde, J.M.G.H. van Riel, A.J. van de Wouw, M.W. Dercksen, N.A.J.B. Peters, F.P.J. Peters, M. de Boer, Vivianne C. G. Tjan-Heijnen, Adri C. Voogd, Petronella G. M. Peer, R.J.W. van Kampen, Dorien J.A. Lobbezoo
المساهمون: RS: CAPHRI School for Public Health and Primary Care, RS: CAPHRI - R5 - Optimising Patient Care, RS: GROW - Oncology, Epidemiologie, Metamedica, Interne Geneeskunde, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy
المصدر: British Journal of Cancer, 112(9), 1445-1451. Nature Publishing Group
British Journal of Cancer, 112, 1445-51
British Journal of Cancer, 112, 9, pp. 1445-51
British Journal of Cancerمصطلحات موضوعية: Adult, Oncology, Cancer Research, medicine.medical_specialty, SURGERY, Breast Neoplasms, STAGE IV, RELAPSE, Metastasis, SUBTYPES, SYNCHRONOUS METASTASES, Breast cancer, Internal medicine, HER2, Humans, Medicine, metastatic-free interval, Neoplasm Metastasis, skin and connective tissue diseases, Survival rate, Survival analysis, Aged, Neoplasm Staging, Aged, 80 and over, business.industry, Proportional hazards model, Cancer, WOMEN, Middle Aged, CHEMOTHERAPY, medicine.disease, Combined Modality Therapy, Metastatic breast cancer, Primary tumor, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Survival Rate, Clinical Study, SURVIVAL, PATTERNS, Female, metastatic breast cancer, prognosis, Neoplasm Grading, Neoplasm Recurrence, Local, PRIMARY TUMOR, business, Follow-Up Studies
وصف الملف: application/pdf
-
8
المؤلفون: Maaike de Boer, N.A.J.B. Peters, Roel J.W. van Kampen, Agnes J. van de Wouw, Vivianne C. G. Tjan-Heijnen, Frank P. J. Peters, Franchette W P J van den Berkmortel, Adri C. Voogd, Tineke J. Smilde, Johanna M. G. H. van Riel, M. Wouter Dercksen, George F. Borm, Dorien J.A. Lobbezoo
المساهمون: Epidemiologie, MUMC+: MA Medische Oncologie (9), Interne Geneeskunde, RS: GROW - School for Oncology and Reproduction
المصدر: Breast Cancer Research and Treatment, 141, 3, pp. 507-14
Breast Cancer Research and Treatment, 141(3), 507-514. Springer, Cham
Breast Cancer Research and Treatment, 141, 507-14مصطلحات موضوعية: Oncology, Adult, Cancer Research, medicine.medical_specialty, Neoplasms, Hormone-Dependent, Survival, Receptor, ErbB-2, Bone Neoplasms, Breast Neoplasms, Hormone Receptor/HER2 Positive, Kaplan-Meier Estimate, Breast cancer, Internal medicine, medicine, Humans, skin and connective tissue diseases, Aged, Proportional Hazards Models, Subtypes, Aged, 80 and over, Proportional hazards model, business.industry, Confounding, Middle Aged, medicine.disease, Prognosis, Metastatic breast cancer, Primary tumor, Distant metastases, Hormone receptor, Evaluation of complex medical interventions [NCEBP 2], Lymphatic Metastasis, Cohort, Multivariate Analysis, Female, business